The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cancer pain is one of the most common symptoms in cancer patients. Pain can be caused by cancer, cancer treatment, or a combination of factors.
The global Cancer Pain market was valued at US$ 6198 million in 2023 and is anticipated to reach US$ 8568 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.
This report aims to provide a comprehensive presentation of the global market for Cancer Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Pain.
Report Scope
The Cancer Pain market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Pain companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- BioDelivery Science
- ProStrakan Group
- Teva pharmaceuticals
- Eli-Lilly
- Grunenthal Group
- GW Pharmaceuticals
- Johnson＆Johnson
- Meda Pharmaceuticals
- Orexo
- Sanofi
- WEX Pharmaceuticals
Segment by Type
- Opioids
- Non-Steroidal Anti-Inflammatory Drugs
- Others
Segment by Application
- Radiotherapy
- Chemotherapy
- Hormone Therapy
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Pain companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Pain Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Opioids
1.2.3 Non-Steroidal Anti-Inflammatory Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cancer Pain Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Radiotherapy
1.3.3 Chemotherapy
1.3.4 Hormone Therapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Pain Market Perspective (2019-2030)
2.2 Cancer Pain Growth Trends by Region
2.2.1 Global Cancer Pain Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Pain Historic Market Size by Region (2019-2024)
2.2.3 Cancer Pain Forecasted Market Size by Region (2025-2030)
2.3 Cancer Pain Market Dynamics
2.3.1 Cancer Pain Industry Trends
2.3.2 Cancer Pain Market Drivers
2.3.3 Cancer Pain Market Challenges
2.3.4 Cancer Pain Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Pain Players by Revenue
3.1.1 Global Top Cancer Pain Players by Revenue (2019-2024)
3.1.2 Global Cancer Pain Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Pain Revenue
3.4 Global Cancer Pain Market Concentration Ratio
3.4.1 Global Cancer Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Pain Revenue in 2023
3.5 Cancer Pain Key Players Head office and Area Served
3.6 Key Players Cancer Pain Product Solution and Service
3.7 Date of Enter into Cancer Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Pain Breakdown Data by Type
4.1 Global Cancer Pain Historic Market Size by Type (2019-2024)
4.2 Global Cancer Pain Forecasted Market Size by Type (2025-2030)
5 Cancer Pain Breakdown Data by Application
5.1 Global Cancer Pain Historic Market Size by Application (2019-2024)
5.2 Global Cancer Pain Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Pain Market Size (2019-2030)
6.2 North America Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Pain Market Size by Country (2019-2024)
6.4 North America Cancer Pain Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Pain Market Size (2019-2030)
7.2 Europe Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Pain Market Size by Country (2019-2024)
7.4 Europe Cancer Pain Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Pain Market Size (2019-2030)
8.2 Asia-Pacific Cancer Pain Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Pain Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Pain Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Pain Market Size (2019-2030)
9.2 Latin America Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Pain Market Size by Country (2019-2024)
9.4 Latin America Cancer Pain Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Pain Market Size (2019-2030)
10.2 Middle East & Africa Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Pain Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Pain Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BioDelivery Science
11.1.1 BioDelivery Science Company Detail
11.1.2 BioDelivery Science Business Overview
11.1.3 BioDelivery Science Cancer Pain Introduction
11.1.4 BioDelivery Science Revenue in Cancer Pain Business (2019-2024)
11.1.5 BioDelivery Science Recent Development
11.2 ProStrakan Group
11.2.1 ProStrakan Group Company Detail
11.2.2 ProStrakan Group Business Overview
11.2.3 ProStrakan Group Cancer Pain Introduction
11.2.4 ProStrakan Group Revenue in Cancer Pain Business (2019-2024)
11.2.5 ProStrakan Group Recent Development
11.3 Teva pharmaceuticals
11.3.1 Teva pharmaceuticals Company Detail
11.3.2 Teva pharmaceuticals Business Overview
11.3.3 Teva pharmaceuticals Cancer Pain Introduction
11.3.4 Teva pharmaceuticals Revenue in Cancer Pain Business (2019-2024)
11.3.5 Teva pharmaceuticals Recent Development
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Detail
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Cancer Pain Introduction
11.4.4 Eli-Lilly Revenue in Cancer Pain Business (2019-2024)
11.4.5 Eli-Lilly Recent Development
11.5 Grunenthal Group
11.5.1 Grunenthal Group Company Detail
11.5.2 Grunenthal Group Business Overview
11.5.3 Grunenthal Group Cancer Pain Introduction
11.5.4 Grunenthal Group Revenue in Cancer Pain Business (2019-2024)
11.5.5 Grunenthal Group Recent Development
11.6 GW Pharmaceuticals
11.6.1 GW Pharmaceuticals Company Detail
11.6.2 GW Pharmaceuticals Business Overview
11.6.3 GW Pharmaceuticals Cancer Pain Introduction
11.6.4 GW Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)
11.6.5 GW Pharmaceuticals Recent Development
11.7 Johnson＆Johnson
11.7.1 Johnson＆Johnson Company Detail
11.7.2 Johnson＆Johnson Business Overview
11.7.3 Johnson＆Johnson Cancer Pain Introduction
11.7.4 Johnson＆Johnson Revenue in Cancer Pain Business (2019-2024)
11.7.5 Johnson＆Johnson Recent Development
11.8 Meda Pharmaceuticals
11.8.1 Meda Pharmaceuticals Company Detail
11.8.2 Meda Pharmaceuticals Business Overview
11.8.3 Meda Pharmaceuticals Cancer Pain Introduction
11.8.4 Meda Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)
11.8.5 Meda Pharmaceuticals Recent Development
11.9 Orexo
11.9.1 Orexo Company Detail
11.9.2 Orexo Business Overview
11.9.3 Orexo Cancer Pain Introduction
11.9.4 Orexo Revenue in Cancer Pain Business (2019-2024)
11.9.5 Orexo Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Detail
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Cancer Pain Introduction
11.10.4 Sanofi Revenue in Cancer Pain Business (2019-2024)
11.10.5 Sanofi Recent Development
11.11 WEX Pharmaceuticals
11.11.1 WEX Pharmaceuticals Company Detail
11.11.2 WEX Pharmaceuticals Business Overview
11.11.3 WEX Pharmaceuticals Cancer Pain Introduction
11.11.4 WEX Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)
11.11.5 WEX Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
